3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
67
Pancreatic Neoplasms
34
Neoplasm Metastasis
22
Neuroblastoma
21
Neoplasms
16
Colonic Neoplasms
15
Stomach Neoplasms
13
Rectal Neoplasms
13
Sarcoma, Ewing
8
Rhabdomyosarcoma
8
Esophageal Squamous Cell Carcinoma
8
Small Cell Lung Carcinoma
7
Sarcoma
7
Ovarian Neoplasms
6
Lung Neoplasms
6
Cholangiocarcinoma
6
Esophageal Neoplasms
5
Breast Neoplasms
5
Adenocarcinoma Of Esophagus
5
Medulloblastoma
4
Gastrointestinal Neoplasms
4
Endometrial Neoplasms
4
Biliary Tract Neoplasms
4
Adenocarcinoma
4
Recurrence
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Osteosarcoma
3
Glioma
3
Glioblastoma
3
Ganglioneuroblastoma
3
Interventions
Capecitabine
6
Oxaliplatin
5
camrelizumab
2
Radiation
2
Irinotecan
2
toripalimab
1
tislelizumab
1
spartalizumab
1
sintilimab
1
Radiotherapy, Intensity-Modulated
1
Leucovorin
1
Immune Checkpoint Inhibitors
1
Folfox protocol
1
Fluorouracil
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Locally Advanced Rectal Cancer
×
Irinotecan
×
1 year
×
Clear all
NCT05412082
2026-02-06
SMART TNT
University of Miami
Phase 1
Recruiting
25 enrolled
NCT02605265
2025-08-28
CinClare
Fudan University
Phase 3
Completed
356 enrolled